MedPath
TGA Approval

ARIPENA aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kit (444951)

444951

ARIPENA aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kit

Sun Pharma ANZ Pty Ltd

February 12, 2025

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/e0b9362241eac4f0c97be37e5c289791.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/6ffe2df4c8c13d244d6c958b29544b76.pdf

Active Ingredients

aripiprazole monohydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ARIPENA aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kit (444951) - TGA 批准文号 | MedPath